Who are DSP-5423P Active-to-Flex's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dsp-5423p-active-to-flex.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

DSP-5423P Active-to-Flex — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DSP-5423P Active-to-Flex (DSP-5423P Active-to-Flex) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Dopamine D1 receptor partial agonist. Area: Neurology/Psychiatry.

phase 3 Dopamine D1 receptor partial agonist Dopamine D1 receptor (DRD1) Neurology/Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

DSP-5423P Active-to-Flex (DSP-5423P Active-to-Flex) — Sumitomo Pharma Co., Ltd.. DSP-5423P is a selective dopamine D1 receptor partial agonist designed to modulate dopaminergic signaling in the central nervous system.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
DSP-5423P Active-to-Flex TARGET	DSP-5423P Active-to-Flex	Sumitomo Pharma Co., Ltd.	phase 3	Dopamine D1 receptor partial agonist	Dopamine D1 receptor (DRD1)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Dopamine D1 receptor partial agonist class)

Sumitomo Pharma Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DSP-5423P Active-to-Flex — Competitive Intelligence Brief. https://druglandscape.com/ci/dsp-5423p-active-to-flex. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing